Why Is Assurant (AIZ) Up 3.5% Since Last Earnings Report?

Assurant (AIZ) shares have risen 3.5% since its last earnings report, despite underperforming the S&P 500 and downward trending earnings estimates, resulting in a Zacks Rank #3 (Hold) indicating expectations for an in-line return in the near term. Within the same industry, MetLife (MET) has gained 2.7% over the past month, reporting a 10.6% year-over-year revenue increase to $18.83 billion and EPS of $1.96; MetLife also holds a Zacks Rank #3 (Hold).

Analysis

Assurant (AIZ) has experienced a 3.5% share price increase since its last earnings report, though this performance trails the S&P 500. Despite this recent positive momentum, reflected in its Momentum Score of A, analyst earnings estimates for AIZ have trended downward over the past month, signaling a potential shift in outlook. This is further compounded by a subpar Growth Score of D, although its Value Score of B places it in the top 40% for that investment strategy. Collectively, these factors result in an aggregate VGM Score of C and a Zacks Rank #3 (Hold), suggesting expectations for in-line market performance in the coming months. In comparison, industry peer MetLife (MET) saw a 2.7% gain over the past month. MetLife reported a 10.6% year-over-year revenue increase to $18.83 billion and an EPS of $1.96 for its quarter ended March 2025, up from $1.83 a year prior. For the current quarter, MetLife's EPS is projected at $2.32, a 1.8% increase year-over-year, although its Zacks Consensus Estimate has seen a slight -0.4% revision in the last 30 days. MetLife also holds a Zacks Rank #3 (Hold) and a VGM Score of B, indicating a generally cautious but stable outlook within the multi-line insurance sector.

Key Decisions for Investors

• Given Assurant's Zacks Rank #3 (Hold) and downward trending earnings estimates, investors should exercise caution despite the recent 3.5% share price increase and strong Momentum Score; a 'hold' stance may be appropriate pending new catalysts.
• Monitor upcoming earnings releases and subsequent analyst estimate revisions for Assurant closely, as these will be critical in determining if the recent positive price trend can be sustained against fundamental headwinds.
• Note that both Assurant and its peer MetLife carry 'Hold' ratings, suggesting broader sector sentiment may warrant a neutral positioning until more definitive positive or negative indicators emerge for individual names.